Abstract: Aspects of the present disclosure provide a monitoring algorithm that ensures that each step of an automated virtual machine reclamation process executes correctly before moving on to the next step. After each step of the process, some implementations can determine whether the resulting data is correct. If the resulting data is incorrect, some implementations can initially revert any fields updated by the process to their correct value. Some implementations can further decide whether to resubmit the virtual machine for reclamation automatically, or queue it for manual review based on, for example, multiple or repeated failures, server or data center failures, etc. Thus, some implementations can not only automate each step of the reclamation process, but also provide process evaluation and error detection for the reclamation process.

Abstract: The present invention relates to nucleic acid molecules for use in the treatment or prevention of disease.

Abstract: A system, an apparatus and a method of determining refined petiole nutrient values based on leaf spectral data are provided. The method includes storing leaf spectral data in a memory, transforming, using a processor, the leaf spectral data into preliminary petiole nutrient values by inputting the leaf spectral data into one or more linear machine learning models trained to provide petiole nutrient value outputs based on leaf spectral data inputs, and refining, using the processor, the preliminary petiole nutrient values by inputting the preliminary petiole nutrient values into one or more non-linear machine learning models. The one or more non-linear machine learning models are trained to provide refined petiole nutrient value outputs based on preliminary petiole nutrient value inputs.

Abstract: The present invention provides novel nucleic acid compound suitable for therapeutic use. Additionally, the present invention provides methods of making these compounds, as well as methods of using such compounds for the treatment of various diseases and conditions.

Abstract: The present invention relates to inhibitors, and compositions containing inhibitors, and uses of the same in the treatment or prevention of diabetes.

Abstract: The present invention relates to novel conjugated oligonucleotide compounds, which are suitable for therapeutic use. Additionally, the present invention provides methods of making these compounds, as well as methods of using such compounds for the treatment of various diseases and conditions.

Abstract: The present invention relates to nucleic acid molecules for use in the treatment or prevention of disease.

Abstract: The present invention provides novel conjugated oligonucleotide compounds, which are suitable for therapeutic use. Additionally, the present invention provides methods of making these compounds, as well as methods of using such compounds for the treatment of various diseases and conditions.

Abstract: An application health monitoring and reporting system is disclosed herein that allows managers of an application to have real-time visibility to the health of the application and which reports any issues associated with the application. The system is able to identify the issue(s) of why a particular service or micro-services, an icon, a picture or image or any item that is presented on a webpage as part of the application, as well as the failure, status of the failure, estimated time for resolving the failure, along with a hyperlink to view the full details of the failure which contains a summary of the overall health of the services. This system may help to monitor and report the issues in the production of applications, networks, underlying hardware/software components, and any other components.

Abstract: The method for preventing progression to Type II Diabetes includes determining whether a subject possesses a risk variant expression profile demonstrating dysregulation of the IL-33/ST2 axis, and providing an intervention to prevent progression to Type II Diabetes and/or to reverse prediabetes, including modifications of diet and exercise, administration of one or more pharmaceutical compounds, or a combination thereof. The method may be useful to reduce the risk of developing complications associated with Type II Diabetes or prediabetes, such as heart disease, stroke, or obesity. The pharmaceutical compound may be one or more pharmaceuticals capable of reducing circulating cholesterol, reducing blood glucose levels, reducing blood pressure, or a combination thereof.

Abstract: Screening of entities using multi-level rules and tolerances against entity data. The entity data are screened for multiple entities, including determining if the entity data comply with business activity rules. If a respective entity fails to comply with the business activity rules, investments with the non-compliant entity are added to a list of non-usable investments. If the respective entity complies with the business activity rules, the respective entity is identified as a business-activity-compliant entity. Each respective business-activity-compliant entity is then screened using multiple screening methodologies, which are applied to screen the entity data for the respective business-activity-compliant entity against each of the financial rules in accordance with the respective screening methodology.

Abstract: The method for preventing progression to Type II Diabetes includes determining whether a subject possesses a risk variant expression profile demonstrating dysregulation of the IL-33/ST2 axis, and providing an intervention to prevent progression to Type II Diabetes and/or to reverse prediabetes, including modifications of diet and exercise, administration of one or more pharmaceutical compounds, or a combination thereof. The method may be useful to reduce the risk of developing complications associated with Type II Diabetes or prediabetes, such as heart disease, stroke, or obesity. The pharmaceutical compound may be one or more pharmaceuticals capable of reducing circulating cholesterol, reducing blood glucose levels, reducing blood pressure, or a combination thereof.

Abstract: Screening of entities using multi-level rules and tolerances against entity data. The entity data are screened for multiple entities, including determining if the entity data comply with business activity rules. If a respective entity fails to comply with the business activity rules, investments with the non-compliant entity are added to a list of non-usable investments. If the respective entity complies with the business activity rules, the respective entity is identified as a business-activity-compliant entity. Each respective business-activity-compliant entity is then screened using multiple screening methodologies, which are applied to screen the entity data for the respective business-activity-compliant entity against each of the financial rules in accordance with the respective screening methodology.

Abstract: The invention relates to a device for performing respiratory training, in particular altitude training, comprising a mouthpiece (1) through which a person can exhale respiratory gas into a volume (2, 3a, 7) or can inhale it out of the volume (2, 3a, 7), wherein this volume (2, 3a, 7) is formed at least in part by a container (2) which is adjustable in terms of its volume and which is connected to the mouthpiece, wherein the volume (2, 3a, 7) adjoins one side of at least one gas-permeable membrane (4), to the other side of which at least one gas exchange chamber (3b) is connected, through which a fluid provided for the gas exchange, in particular CO2 and/or O2 gas exchange, can actively flow.

Abstract: A method of manufacturing indium tin oxide includes sputtering indium and tin from a target onto a substrate, the sputtering including moving the target along a path over the substrate. The indium tin oxide may have a sheet resistance less than 0.5 ?/?. An indium film includes: a first moving target sputtered indium tin oxide layer; a second moving target sputtered indium tin oxide layer on the first moving target sputtered indium tin oxide layer; and a third moving target sputtered indium tin oxide layer on the second moving target sputtered indium tin oxide layer. A transparency includes the indium tin oxide, and a flying vehicle includes the transparency.

Abstract: A method of manufacturing indium tin oxide includes sputtering indium and tin from a target onto a substrate, the sputtering including moving the target along a path over the substrate. The indium tin oxide may have a sheet resistance less than 0.5 ?/?. An indium film includes: a first moving target sputtered indium tin oxide layer; a second moving target sputtered indium tin oxide layer on the first moving target sputtered indium tin oxide layer; and a third moving target sputtered indium tin oxide layer on the second moving target sputtered indium tin oxide layer. A transparency includes the indium tin oxide, and a flying vehicle includes the transparency.

Abstract: The invention relates to an apparatus and a process for mass- and/or energy-transfer between two media, in particular between blood and a gas/gas mixture, having a chamber (1) through which a first medium, in particular blood, flows and in which a bundle of mass- and/or energy-permeable hollow fibers through which the second medium can flow and around which the first medium can flow is arranged transverse to the flow direction of the first medium, in which the chamber (1) is configured as an elastic shell (3) at least in a region which completely surrounds the bundle, where a rigid housing (6) is arranged around the elastic shell (3) and the inner wall of the housing contacts the shell (3) in a plurality of first regions (9) and the inner wall of the housing is not in contact with and is in particular at a spacing from the shell (3) in at least one second region (10), preferably a plurality of second regions (10) in the direction of the extension of the hollow fibers, where the one hollow space or at least on

Abstract: A method of manufacturing indium tin oxide includes sputtering indium and tin from a target onto a substrate, the sputtering including moving the target along a path over the substrate. The indium tin oxide may have a sheet resistance less than 0.5?/?. An indium film includes: a first moving target sputtered indium tin oxide layer; a second moving target sputtered indium tin oxide layer on the first moving target sputtered indium tin oxide layer; and a third moving target sputtered indium tin oxide layer on the second moving target sputtered indium tin oxide layer. A transparency includes the indium tin oxide, and a flying vehicle includes the transparency.

Abstract: The present invention provides compounds of general formula A, useful as potential anti-tubercular agents against Mycobacterium tuberculosis H37Rv, and drug-resistant Mycobacterium tuberculosis and a process for the preparation thereof wherein, n=5-12 n1=0,1 R=CF3 or Cl.

Abstract: The invention relates to an apparatus and a process for mass- and/or energy-transfer between two media, in particular between blood and a gas/gas mixture, having a chamber (1) through which a first medium, in particular blood, flows and in which a bundle of mass- and/or energy-permeable hollow fibres through which the second medium can flow and around which the first medium can flow is arranged transverse to the flow direction of the first medium, in which the chamber (1) is configured as an elastic shell (3) at least in a region which completely surrounds the bundle, where a rigid housing (6) is arranged around the elastic shell (3) and the inner wall of the housing contacts the shell (3) in a plurality of first regions (9) and the inner wall of the housing is not in contact with and is in particular at a spacing from the shell (3) in at least one second region (10), preferably a plurality of second regions (10) in the direction of the extension of the hollow fibres, where the one hollow space or at least on